文献速递肝病消化道肿瘤与早癌

ErbB/HER受体酪氨酸激酶家族在胆管细胞生物学中的作用

Role of ErbB/HER family of receptor tyrosine kinases in cholangiocyte biology.
PubMed 文献 · Hepatology · 2017-12-26

本文综述ErbB/HER受体家族(EGFR/ErbB1/HER1、ErbB2/HER2、ErbB3/HER3、ErbB4/HER4)在胆管细胞生物学中的作用。现有知识提示EGFR参与胆管细胞特化与增殖,并在肝再生过程中参与肝细胞向胆管细胞转分化以恢复胆管上皮完整性。EGFR和/或ErbB2的高表达与活化已在胆石症和原发性硬化性胆管炎中被证实,在胆管癌中ErbB受体常过表达并导致肿瘤进展和预后不良;抗ErbB治疗仅在临床前试验中有效,并提示存在耐药机制。

要点

  • ErbB家族包括EGFR/ErbB1/HER1、ErbB2/HER2、ErbB3/HER3和ErbB4/HER4四个受体。
  • EGFR参与胆管细胞特化与增殖,以及肝再生中肝细胞向胆管细胞转分化。
  • 胆石症和原发性硬化性胆管炎中可见EGFR和/或ErbB2高表达与活化。

核心结论

  • 现有知识提示EGFR在胆管细胞特化和增殖中发挥作用,并在肝再生过程中参与肝细胞向胆管细胞转分化以恢复胆管上皮完整性。
  • EGFR和/或ErbB2的高表达和活化已在胆石症和原发性硬化性胆管炎中被证实,这两种胆管病被视为胆管癌的危险因素。
  • 在胆管癌中ErbB受体常过表达,导致肿瘤进展和预后不良;抗ErbB治疗仅在临床前试验中有效,并提示存在耐药机制,需要识别治疗反应的预测因素。

研究设计与样本

  • 本文为综述,旨在汇编关于ErbB受体在胆管上皮生理学和病理生理学中功能的当前知识。

主要发现

  • ErbB家族包含四个不同的酪氨酸激酶受体:EGFR/ErbB1/HER1、ErbB2/HER2、ErbB3/HER3和ErbB4/HER4,触发分化、增殖、存活和迁移等基本细胞功能的细胞内信号。
  • 衬覆肝内和肝外胆管的胆管细胞对胆汁分泌功能和胆汁运输有重要贡献。
  • 尽管ErbB受体在胆管癌中已被广泛研究,但对其在胆管上皮生理学和非恶性胆管病中的认识远未完整。
  • EGFR和/或ErbB2的高表达和活化近期在胆石症和原发性硬化性胆管炎中被证实,这两种胆管病被视为胆管癌的危险因素。
  • 在胆管癌中ErbB受体常过表达,导致肿瘤进展和预后不良;抗ErbB治疗仅在临床前试验中有效,并提示存在耐药机制,需要识别治疗反应的预测因素。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文指出,尽管ErbB受体在胆管癌中已被广泛研究,但对其在胆管上皮生理学和非恶性胆管病中的认识远未完整。
  • 原文指出,抗ErbB治疗仅在临床前试验中有效,并提示存在耐药机制,需要识别治疗反应的预测因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The ErbB/HER family comprises four distinct tyrosine kinase receptors, EGFR/ErbB1/HER1, ErbB2/HER2, ErbB3/HER3, and ErbB4/HER4, which trigger intracellular signals at the origin of essential cellular functions, including differentiation, proliferation, survival, and migration. Epithelial cells, named cholangiocytes, that line intrahepatic and extrahepatic bile ducts, contribute substantially to biliary secretory functions and bile transport. Although ErbB receptors have been widely studied in cholangiocarcinoma (CCA), a malignancy of the biliary tract, knowledge of these receptors in biliary epithelium physiology and in non-malignant cholangiopathies is far from complete. Current knowledge suggests a role for epidermal growth factor receptor (EGFR) in cholangiocyte specification and proliferation, and in hepatocyte transdifferentiation into cholangiocytes during liver regeneration to restore biliary epithelium integrity. High expression and activation of EGFR and/or ErbB2 were recently demonstrated in biliary lithiasis and primary sclerosing cholangitis, two cholangiopathies regarded as risk factors for CCA. In CCA, ErbB receptors are frequently overexpressed, leading to tumor progression and low prognosis. Anti-ErbB therapies were efficient only in preclinical trials and have suggested the existence of resistance mechanisms with the need to identify predictive factors of therapy response. This review aims to compile the current knowledge on the functions of ErbB receptors in physiology and physiopathology of the biliary epithelium. (Hepatology 2018;67:762-773).

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Pellat A, Vaquero J, Fouassier L, et al. Role of ErbB/HER family of receptor tyrosine kinases in cholangiocyte biology. Hepatology. 2017. PMID: 28671339. doi:10.1002/hep.29350

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。